Celanese (NYSE: CE) director adds 2,400 shares in open-market buy

Rhea-AI Filing Summary

Celanese Corp director Edward G. Galante reported an open-market purchase of 2,400 shares of Celanese common stock. The trade occurred on August 14, 2025 at a reported weighted average price of $41.272 per share, based on multiple transactions between $40.98 and $41.45.

After this purchase, Galante directly beneficially owned 21,377 Celanese shares, according to the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GALANTE EDWARD G

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W. LAS COLINAS BLVD., SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		P		2,400	A	$41.272(1)	21,377	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.45. The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese (CE) report for Edward G. Galante?

Celanese director Edward G. Galante reported buying 2,400 shares of Celanese common stock. The Form 4 shows this open-market purchase increased his direct beneficial ownership to 21,377 shares following the transaction on August 14, 2025, according to the filing details.

On what date did Edward G. Galante buy Celanese (CE) shares and at what price?

Edward G. Galante bought Celanese shares on August 14, 2025. The reported weighted average price was $41.272 per share, with multiple trades executed in a price range from $40.98 to $41.45 during that trading day, as disclosed in the footnote.

How many Celanese (CE) shares does Edward G. Galante own after this Form 4 transaction?

After the reported transaction, Edward G. Galante directly beneficially owned 21,377 Celanese shares. This total reflects his holdings following the open-market purchase of 2,400 additional shares on August 14, 2025, as stated in the ownership column of the Form 4 filing.

What type of transaction is shown in Edward G. Galante’s Celanese (CE) Form 4?

The Form 4 shows an open-market purchase of common stock by Edward G. Galante. The transaction is coded “P,” indicating a purchase in an open market or private transaction, and it involves 2,400 non-derivative common shares of Celanese Corporation on August 14, 2025.

Is Edward G. Galante’s Celanese (CE) share ownership direct or indirect?

The Form 4 indicates that Edward G. Galante’s reported Celanese share ownership is direct. The ownership code is listed as “D” for direct, and there is no separate nature of indirect beneficial ownership disclosed for these 21,377 common shares after the reported purchase.